CME and CFTC Clash Over On-Chain Perpetual Futures

The feud between the CME Group, the largest derivatives exchange operator in the US, and its regulator, the Commodity Futures Trading Commission, has reached a boiling point over the agency's decision to allow blockchain-based perpetual futures products. The CME has sued the CFTC, challenging its decision to permit the listing of crypto perpetual futures, also known as perps, by platforms such as Kalshi and Coinbase. The lawsuit argues that these products are harmful to the CME's traditional futures contracts and that the CFTC's approval did not consider the potential consequences. The CME claims that perps are not futures, as they do not have an expiration date, and therefore should not be subject to the same regulations. The CFTC, on the other hand, has determined that a case-by-case review process is sufficient for approving perps, and has already granted approval to Kalshi's debut offering, which reached over $1 billion in trading volume in less than a week. The dispute has sparked a heated debate, with some arguing that the CME is trying to stifle innovation and competition, while others see the CFTC's approach as a threat to the stability of the financial markets. The outcome of this battle will have significant implications for the US approach to the rapidly growing market of perpetual futures, which has already seen non-US volumes reach $60 trillion in the last year.